Effect of Lowering Blood Pressure and Cholesterol on Risk for Cognitive Decline in Diabetics
Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus.
Are Statins Causing Diabetes? Disturbing Link Found.
Patients that were prescribed statins were 87% more likely to develop diabetes, even though they were free of heart disease, diabetes, and other severe...
Personalized Nutrition Beats “One Size Fits All” Approach in Dieting
A new study has found that a personalized, or individualized, approach to dieting is more effective than the one-size-fits-all approach many people are encouraged...
Study Shows Difference In Cardiovascular Effects Between Vioxx And Celebrex
Researchers found a greater risk of heart attack associated with Vioxx than Celebrex.
Taking Statins Before Aneurysm Repair Improves Outcomes
According to research published in Vascular, patients taking cholesterol-lowering statins before endovascular aortic aneurysm surgery are more likely to survive. Rupture of an abdominal aortic...
Possible Mechanism For Link Between Diabetes and Alzheimer’s Disease Discovered
Insulin resistance in brain cells can affect how they function, causing some of the biochemical changes typically seen in Alzheimer's disease.
Cooking Oil to Fight Fat and Cholesterol?
Study of new blend of cooking oil that enables people to heighten their metabolism, lower their cholesterol and, in some cases, lose weight.
No Good Evidence That Cholesterol Drugs Lower Melanoma Risk
No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.
New Cholesterol Guidelines Released
The National Cholesterol Education Program (NCEP) issued major new clinical practice guidelines on the prevention and management of high cholesterol in adults. The guidelines are the first major update from NCEP in nearly a decade.
New Cholesterol Disorder Discovered – As Predicted From Gene’s Role
A team lead by UCSF medical researchers has discovered a new disorder that can cause severely elevated blood cholesterol levels and may affect several hundred thousand people in the U.S. and Europe to varying degrees. The malady is caused by a single gene defect.
FDA Approves First Generic Pravastatin
The Food and Drug Administration approved the first generic version of Bristol-Myers Squibb's Pravachol (Pravastatin Sodium Tablets).
Do Eggs Have a Lipid That Lowers Cholesterol Absorption?
Nutrition researchers at Kansas State University have published the first evidence that the absorption of cholesterol is reduced by another compound in the egg, a lecithin.
False Sense of Security Among Statin Users Leading to Heart Disease and Illnesses
People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.
Study Shows Patients Taking Lipitor Show Significant Cardiovascular Benefit
Preliminary results showed diabetic patients who took the cholesterol-lowering medicine Lipitor had significantly fewer heart attacks, strokes and surgical procedures compared to patients who received placebo.
ACE Inhibitors Reduce Kidney Disease Risk in Diabetics with High Blood Pressure
In diabetic patients with hypertension, ACE inhibitors reduce the risk of developing diabetes-related kidney disease, independent of their effect in lowering blood pressure, reports a study in the December Journal of the American Society of Nephrology.
Widely Used Cholesterol Medicine May Increase Muscle Pain
Up to 75-percent of patients who take a widely used cholesterol medicine to treat high cholesterol may end up suffering from muscle pain.
